RBM35B inhibitors are a class of chemical compounds that specifically target and inhibit the activity of RBM35B, an RNA-binding protein involved in the regulation of alternative splicing and other post-transcriptional processes. RBM35B, a member of the RNA-binding motif (RBM) protein family, plays a key role in the modulation of mRNA splicing, a process that determines how exons are included or excluded during mRNA maturation. This process is crucial for generating protein diversity, allowing a single gene to produce multiple protein isoforms with different functions. RBM35B contains RNA recognition motifs (RRMs) that enable it to interact with specific pre-mRNA sequences, influencing the splicing machinery to include or exclude certain exons. Inhibitors of RBM35B typically function by binding to its RNA-binding domains or other functional sites, disrupting its ability to regulate RNA processing.
The inhibition of RBM35B leads to significant alterations in splicing patterns, impacting the expression of key proteins involved in various cellular processes. By blocking RBM35B from performing its regulatory functions, these inhibitors prevent the proper formation of mRNA isoforms, which can disrupt cellular functions dependent on specific protein variants. Researchers use RBM35B inhibitors as tools to study the mechanisms of alternative splicing regulation and to explore how this protein contributes to post-transcriptional control in different biological contexts. These inhibitors also provide insights into the broader networks of RNA-binding proteins and how they coordinate the complex process of gene regulation. Studying RBM35B inhibitors allows scientists to better understand the role of splicing in cellular differentiation, development, and adaptation, as well as how disruptions in splicing regulation can affect normal cellular function. Through this research, scientists gain a deeper understanding of the molecular mechanisms governing RNA processing and the broader impact of RNA-binding proteins like RBM35B on gene expression and protein diversity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
May demethylate the RBM35B gene, potentially affecting its transcription and expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Could influence DNA methylation patterns, possibly affecting RBM35B gene expression. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
Might inhibit DNA methyltransferases, potentially impacting RBM35B expression. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $129.00 $284.00 $1004.00 | 3 | |
Could affect DNA methylation and possibly influence RBM35B expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Might modify histone acetylation and potentially influence RBM35B transcription. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
Could affect histone modification, potentially impacting RBM35B expression. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
May modify histone acetylation levels, potentially affecting RBM35B expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Might inhibit histone deacetylases, potentially affecting RBM35B gene expression. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Could modify histone acetylation, possibly impacting RBM35B expression. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
May influence histone acetylation, potentially affecting RBM35B transcription. | ||||||